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Background: Ukraine has one of the most severe HIV epidemics in Eastern Europe, with an estimated 1.6% of the
adult population living with the virus. Injection drug use accounts for 36% of new HIV cases. Nongovernmental
organizations in Ukraine have little experience with effective, theory-based behavioral risk reduction interventions
necessary to reduce the scope of the HIV epidemic among Ukrainians who inject drugs. This study seeks to promote
the use of evidence-based HIV prevention strategies among Ukrainian organizations working with drug users.
Methods/design: This study combines qualitative and quantitative methods to explore a model of HIV prevention
intervention development and implementation that disseminates common factors of effective behavioral risk
reduction interventions and enables service providers to develop programs that reflect their specific
organizational contexts. Eight agencies, located in regions of Ukraine with the highest HIV and drug use rates and
selected to represent key organizational context criteria (e.g., agency size, target population, experience with HIV
prevention), will be taught common factors as the basis for intervention development. We will use qualitative
methods, including interviews and observations, to document the process of intervention development and
implementation at each agency. Using risk assessments with intervention participants, we will also assess
intervention effectiveness.
The primary outcome analyses will determine the extent to which agencies develop and implement an
intervention for drug users that incorporates common factors of effective behavioral interventions. Effectiveness
analyses will be conducted, and effect size of each intervention will be compared to that of published HIV
prevention interventions for drug users with demonstrated effectiveness. This study will explore the role of
organizational context on intervention development and implementation, including resource allocation decisions,
problem-solving around intervention development, and barriers and facilitators to inclusion of common factors
and delivery of a high quality intervention.
Discussion: This innovative approach to HIV prevention science dissemination and intervention development
draws on providers’ ability to quickly develop innovative programs and reach populations in greatest need of
services. It has the potential to enhance providers’ ability to use HIV prevention science to develop sustainable
interventions in response to a rapidly changing epidemic.
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HIV among people who inject drugs (PWID) in Ukraine
In Ukraine, annual HIV diagnoses have more than
doubled each year since 2001 [1,2]. Injection drug use
accounts for 36% of new HIV cases, and the majority of
HIV infection occurs among PWID and their sex partners
[3,4]. The unique drug use practices among Ukraine
PWID and their associated HIV risks require tailored,
context-specific prevention interventions. In Ukraine,
locally produced opiates are often obtained in liquefied
form either in pre-loaded syringes, or from a common
container. Drugs are often distributed by frontloading
or backloading the solution from the dealer’s syringe
into the users’ syringes [3]. Loading from common sy-
ringes contributes to HIV risk because up to 12 unre-
lated PWID may load their syringes from the dealer’s
same equipment, and the drug solution may be contam-
inated and passed to other users. In addition, Ukrainian
PWID typically inject in groups of network members,
and share both drug solution and needles/syringes [5].
Needle exchange programs are unlikely to decrease the
indirect sharing that occurs as a result of the prevalence
opiates in liquefied form [6]. Current evidence-based
interventions (EBIs) for drug users do not specifically
incorporate information about these unique injection
drug use risks and would require significant tailoring to
increase their relevance for Ukrainian PWID.
The role of nongovernmental organizations in HIV
prevention
Nongovernmental organizations (NGOs) are the primary
providers of HIV prevention services for PWID in
Ukraine. Historically, NGOs initiated the response to the
AIDS epidemic, and they have remained the primary
providers of HIV prevention services and programs [7].
NGOs are able to promote local involvement, develop
and implement low-cost programs, and adapt and innovate
in response to changing conditions at the local level [8].
NGOs also have the ability to reach the most stigma-
tized, marginalized, and at-risk populations, such as
PWID and their sex partners, commercial sex workers,
and men who have sex with men [7]. In Eastern Europe,
these groups are often ignored or misunderstood by
governmental HIV prevention initiatives, and are dis-
trustful of governmental programs and workers [9].
Currently, NGOs primarily conduct needle exchange
programs, one-on-one direct outreach, peer education,
and AIDS information dissemination [9]. While provision
of sterile injection equipment is important and has been
shown to reduce new HIV infections among PWID
[10,11], such programs alone do not address sexual HIV
risk among drug users [12]. Moreover, although education
efforts among Ukrainian PWID have resulted in high
levels of knowledge about HIV transmission and how toreduce risk of infection, it has not reduced their HIV
infection rates [4].Barriers to adoption and implementation of EBIs
The capacity of NGOs to implement resource-intensive,
theoretically informed interventions presents a significant
barrier to widespread incorporation of evidence-based
interventions into local programming [13]. EBIs often
require a high degree of structure and were developed
and tested in much more controlled settings than exist
in most community organizations [14]. NGO-based pro-
viders commonly work with clients who are much more
variable than research study participants in terms of
age, socioeconomic status, racial/ethnic background,
risk behaviors, and gender [15]. Volunteer or low-paid
staff without experience implementing evidence-based
interventions, high staff turnover rates, small budgets,
and few resources combine to create a challenge to sus-
tainable implementation of externally-developed programs
[7,9,16,17]. Eastern European HIV prevention NGOs
in particular often operate with mean annual budgets
of $55,000 in cities with populations over 1 million
people [9]. In Ukraine, the national HIV program is
significantly underfunded, resulting in lack of financial
support for NGOs working with populations most at-
risk for HIV, including drug users [18,19].The politics of public health policy transfer
When public health policies and interventions are trans-
ferred from the US and other Western countries to new
contexts (particularly low and middle income countries),
they are often met with strong resistance by local experts
who see them as undermining their professional training,
locally-generated solutions, and context-appropriate pro-
grams [20]. They may also resist new programs and ser-
vices that they see as inconsistent with strongly held
values [21]. Moreover, service providers and NGOs are
often ambivalent about research and its implications
for their specific practices [22,23]. Providers and cli-
ents may view the results of research as irrelevant to
their needs if results do not reflect their experience-
generated knowledge, values, or priorities, and if re-
searchers alone define its focus and significance [24].
Providers consider the relative advantage of the new
program over existing services, funding and service ob-
ligations, and resource levels in decisions to implement
new interventions [25]. Top-down dissemination of
researcher-developed interventions undermines this
process and creates resistance to uptake of these programs;
as a result, community-based service providers may
prefer their ‘homegrown’ programs over pre-packaged
interventions [26,27].
Table 1 Common factors of effective behavioral
interventions [46-53]
Implementation Content Pedagogy
Multi-session HIV/AIDS information Peer group
discussion or
interaction
Small group format Risk Identification and
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Initiatives to disseminate EBIs have focused on helping
service providers implement programs with fidelity to core
elements [14,28,29]. ‘Core elements’ are integral compo-
nents of the intervention thought to be responsible for its
effectiveness and that must be retained in order for HIV
risk reduction to occur [18,30,31]. During training, agen-
cies that plan to implement the intervention are instructed
that core elements cannot be ignored, added to, or chan-
ged. However, service providers rarely implement EBIs
with fidelity, despite significant investment of financial,
human, and material resources into dissemination efforts.
Frontline service providers frequently expand interven-
tions to new populations, include most but not all core el-
ements, or reinvent interventions by combining them with
other programs [32-35]. These changes potentially render
the intervention ineffective [32,36]. Agencies that partici-
pate in capacity-building programs continue to experience
high rates of staff turnover, lack access to technical assist-
ance resources, inconsistently evaluate and implement
programs, struggle to recruit and retain intervention
participants, and operate with limited resources while
attempting to implement costly and complex interven-
tions [13,37-39]. At the same time, funding and capacity-
building agencies, in partnership with service providers,
spend significant resources taking interventions developed
through research for one population and adapting and
modifying them to fit new target populations [40]. The
impact of this frontline ‘tailoring’ process on interven-
tion effectiveness, however, is not well-researched. This
process also creates the need to continually adapt each
intervention for each new population, requiring significant
resources and long-term, unsustainable researcher-agency-
funder partnerships. In response to these implementation
shortfalls, dissemination researchers have called for more
attention to the consequences of implementation fidelity
versus adaptation, and models to promote implemen-
tation fidelity among frontline service providers have
proliferated [41,42].
Building better interventions through common factors
dissemination
From a dissemination and implementation perspective,
core elements are often purely theoretical and not easily
translatable to practice; do not capture critical aspects of
the intervention; and lack specificity to guide service
providers in program delivery [43,44]. In contrast, com-
mon factors are broader constructs that support behav-
ior change and are incorporated into a variety of EBIs.
Generally, effective evidence-based prevention strategies
are based on the idea that behavior change requires oppor-
tunities and practice, and that change occurs over time
[45]. Successful HIV prevention interventions include a
framework to understand the HIV risk behavior andchange; cognitive, affective, and behavioral skill-building;
fostering sustainable social support; tailored, behavior-
specific content; and addressing environmental barriers to
behavior change [45]. Factors common to effective behav-
ioral interventions can be categorized into three domains:
implementation, content, and pedagogy. (See Table 1).
Organizational factors that affect implementation
Organizational, provider, and program characteristics influ-
ence the type of intervention an agency develops, and may
hinder or facilitate intervention implementation. At the
organizational level, factors associated with intervention de-
velopment include leadership, organizational commitment
to and support of the new program, decision-making pro-
cesses (e.g., participatory versus autocratic), stability and
adequacy of resources, shared vision and goals within the
organization, willingness to initiate change, and dedicated
staff to implement the intervention [54-57]. Provider char-
acteristics (e.g., demographic, educational) are also associ-
ated with intervention adoption and implementation. In
addition, intervention adoption and implementation is
linked with the intervention’s appeal to providers’ sense of
what will work with their specific populations; belief in the
intervention’s supporting evidence; willingness to follow
either organizational or funding requirements to imple-
ment specific programs; and openness to change [58,59].
In addition, programs that could be implemented by small
numbers of part-time and unpaid staff with few resources
(time, money, space, materials) are more likely to be
adopted and implemented [60,61].
Research methods
Study objectives
The MICT study will explore the extent to which NGOs
in Ukraine can develop an HIV prevention intervention
based on common factors of effective behavioral interven-
tions, and whether these agency-developed interventions
reduce participants’ drug use and sexual HIV risk behav-
iors. We expect that service provider characteristics,
including agency size and resources, mission and goals,
commitment to intervention development, and staff
expertise will affect both intervention development
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into consideration in decisions regarding intervention de-
velopment, including specific content, target population,
number of sessions, and pedagogy. These factors will in-
fluence organizations’ ability to implement the interven-
tions they develop as they modify the intervention in
response to unanticipated barriers and problem-solving
to overcome them.
Study design
This study combines qualitative and quantitative methods
to determine whether Ukrainian NGOs working with
injection drug users can successfully develop and imple-
ment HIV prevention interventions based on common
factors of effective behavioral interventions. We will
teach staff from eight Ukrainian NGOs common factors
of effective behavioral interventions, theoretical con-
cepts identified as important for behavior change, and
key aspects of intervention development. We will docu-
ment the process of intervention development and im-
plementation at each agency. Then, we will document
intervention implementation to assess inclusion of com-
mon factors; aspects of program delivery, including
reach and scope; and effectiveness.
Study sites
We recruited eight HIV prevention organizations that
work with people who inject drugs from regions with theTable 2 MICT study design and data collection phases
Phase Year Data collection Purpose
Baseline 1 Provider questionnaire Assess quantifiable aspects o
Baseline 1 In-depth interviews Assess qualitative dimension
Baseline 1 Organizational histories Document organization orig
population, changes over tim
Baseline 1 Week-long, face-to-face
workshop
Teach NGO staff common fa
intervention development
Development 1 & 2 1-month interviews Document intervention deve
consultation as needed
Development 2 Intervention manual Assess common factors, clea
population
Development 2 Manual checklist Determine if interventions in
clear goals
Development 3 3-month interviews Documentation of interventi
consultation
Implement 2 & 3 Intervention
observations
Determine quality of interve
Implement 3 Common factors
checklist
Assess presence or absence
implementation
Implement 3 & 4 Follow-up interviews Document why common fac
Effectiveness 3 & 4 Baseline & 3-month
assessments
Determine whether intervenhighest HIV prevalence rates, specifically the eastern and
southern regions and the central region [18]. We pur-
posely recruited NGOs to reflect real-world variability in
terms of agency history, size, mission and context. Study
agencies include at least one of each of the following: an
HIV prevention-specific NGO; an IDU-focused NGO
that primarily works through street-level outreach and
information dissemination; a medically-oriented drug
treatment organization; a small NGO that is primarily
volunteer-staffed; and a rights-based NGO that advo-
cates for improved policies toward and better treatment
services for drug users. The differences between these
agency contexts will be a key consideration in final ana-
lyses of intervention development, implementation and
effectiveness.
Data collection
Data collection will occur in 4 phases (Baseline, Inter-
vention Development, Intervention Implementation, Ef-
fectiveness). (See Table 2).
Phase 1 (Baseline)
To assess agency characteristics that potentially affect inter-
vention implementation, NGO directors will complete a
provider questionnaire that will assess organizational cap-
acity and other aspects of implementation context, includ-
ing number of full-time, part-time, and volunteer staff;
staff turnover; types of HIV prevention services provided;Source Total number
f organizational context Agency director n = 8
s of organizational context Agency director,
NGO staff






ctors and train them in Location:
Ukraine
N/A
lopment, provide Agency staff n = 48 (1/site x 8 sites x
6/year)
r goals, well-defined Each agency n = 8
clude common factors, Each agency n = 8
on development; Agency staff n = 32




of common factors in Checklist of
observation
n = 8
tors included or not Intervention
facilitators
n = 16 (1-2 facilitators/
site)
tions reduce participants’ risk Intervention
participants
n = 520 (130/site x
4 sites)
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In-depth interviews with agency staff will assess non-
quantifiable aspects of implementation context and gain
additional perspectives on the agency and HIV prevention
among Ukrainian NGOs, including experiences imple-
menting evidence-based interventions, sense of prepared-
ness to implement a new program, training experience,
and anticipated barriers and facilitators to implementa-
tion. Interviews also will focus on the history of the NGO;
current and future agency goals and scope of HIV pre-
vention activities; and the interviewee’s personal history
of involvement in HIV prevention activities, including
his/her tenure in his/her present position, experience
with the target population, and views on PWID and HIV
risk and prevention strategies [13].
Phase 2 (Intervention development)
During Study Years 1 and 2, following training we will
conduct regular interviews with NGO staff involved in
intervention development. These interviews will focus
on decision-making processes regarding intervention de-
velopment, such as how intervention design is determined;
capacity-building activities the agency has conducted to
prepare for implementation (e.g., additional staff training
or recruitment); development of procedures and rela-
tionships to facilitate intervention implementation (e.g.,
cooperative agreements with partner agencies, partici-
pant recruitment strategies); and barriers to program
development. At the conclusion of Study Year 2, we will
collect each agency’s intervention manual to document
whether an agency’s intervention includes an identifi-
able target population, clear objectives, and common
factors of successful interventions.
Phase 3 (Intervention implementation)
During Study Year 2, we will conduct intervention obser-
vations of a complete intervention cycle at each participat-
ing NGO. Data collected from the video recording will be
used to complete a Common Factors Checklist for each
session at each site that will record whether the interven-
tion includes, somewhat includes, or does not include
common factors of effective behavioral interventions. Two
Common Factors Inclusion Scores (quantitative and quali-
tative) will be calculated for each intervention imple-
mented at each agency. The first score (quantitative) will
use a 2-point scale to capture the presence (1 = included)
or absence (0 = not included) for each common factor
in the implemented intervention. The second score
(qualitative) will use a 4-point scale to capture the qual-
ity of implementation of common factors. For example,
facilitator skills such as ‘subject matter expertise’ will be
scored as: 0 = no expertise; 1 = little expertise; 2 = some
expertise; 3 = adequate expertise; 4 = expert. These two
measures will then be summed and rank orderedseparately, and an overall ranking will be calculated for
each agency based on these two scores. The four agencies
with the highest average ranking will be included in ef-
fectiveness component of the study (Phase 4, described
below). We will conduct analyses of internal validity
(Cronbach’s alpha) for each scale included in the Common
Factors Checklist.
We will conduct follow-up interviews with facilitators
from each site. During the interviews, each facilitator will
be asked questions related to specific elements of the
intervention, and about their motivations for including,
modifying or eliminating common factors, as indicated by
the Checklist. Facilitators also will be asked about agency-
level support (financial, personnel, ideological) for contin-
ued implementation, evaluation activities, perceived ability
to sustain the intervention, number of clients served, is-
sues of client recruitment and retention, and impressions
of client satisfaction. Follow-up interviews also will as-
sess quantifiable aspects of intervention implementa-
tion, including dosage (contact time with participants
and number of sessions) and reach (number and type of
participants served).
Phase 4 (Effectiveness)
To determine intervention effectiveness at each site,
during Study Years 3 and 4, we will conduct baseline
and 3-month risk assessments with intervention partici-
pants enrolled in the interventions at the four agencies
with the highest ranked Common Factors Inclusion
Scores. Intervention participants will be invited to par-
ticipate in this component of the study at the time they
are recruited by the agency to participate in the inter-
vention; all intervention participants who are 18 years
of age or older will be eligible. A total of 130 partici-
pants will complete the risk behavior assessment at each
of the four sites (n = 520).
The assessment instrument will be based on the Risk
Behavior Assessment (RBA); it will be modified slightly
based on the drug use patterns of IDUs in Ukraine. The
RBA assesses demographics, health history, drug use,
and injection and sex-related risk behaviors (frequency,
quantity and duration of use of various drugs including
frequency of injecting drugs; injected opiates or an opi-
ate sedative mix or stimulants; injection with network
members; used a front or backloading method; drew
drugs from a common container; injected with a needle/
syringe after other IDUs; number of times had anal, oral
or vaginal sex with and without a condom in the past
months, had sex with primary and casual partners, and
exchanged sex for money or drugs with or without a
condom; and number of sex partners in past three
months, and same sex partners and partners who use
drugs). We will assess psychosocial constructs believed
to mediate or moderate risky behaviors. HIV risk
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items on a 6-point scale assessing strength of intentions
to reduce HIV risk behavior (alpha = 0.82). HIV-related
vulnerability beliefs will be evaluated using 10 items
scored on 7-point scales with possible responses from
‘very unlikely’ to ‘very likely’ (alpha = 0.75). HIV Risk Re-
duction Skills will be assessed by asking participants
how many times or how often in the past three months
they engaged in HIV preventive behaviors. We will
measure HIV-preventive behavioral skill self-efficacy
using the self-efficacy scale used in the NIMH Multisite
HIV Prevention Trial. Questions about participants’ experi-
ences in the intervention will address benefits of participa-
tion, perceived relevance, whether they would recommend
to peers, and overall experiences.
Outcomes
Primary qualitative analyses will examine the relationship
between variations in intervention development, deliv-
ery and effectiveness at each NGO and qualitative data
regarding these service provider characteristics. These
analyses will also compare and contrast agencies with
different Common Factors Inclusion Scores and inter-
vention effectiveness with respect to similarities and dif-
ferences in the context of intervention implementation.
ACASI risk behavior assessments of intervention partic-
ipants at baseline and three-month follow-up will be com-
bined with agency-intervention characteristics (including
Common Factors scores) in a hierarchical (mixed-effect)
repeated measures analysis of changes in risk behavior
pre- and post-intervention. We will use the software pro-
gram GLIMMIX (v9.2, SAS Institute) — generalized linear
mixed models — to test whether interventions can reduce
participants’ drug use and sexual HIV-risk behaviors
and to explore the influence of intervention and agency
characteristics on any reduction in risk behavior. Risk
assessments will be analyzed to determine whether or
not participants reported decreased injection-risk behav-
iors in the past month and number of acts of unprotected
(without condoms) vaginal or anal intercourse in the past
three months. We will fit a hierarchical Poisson regression
model to examine whether the intervention can reduce
the number of risky drug injections in the past month and
number of unprotected vaginal or anal intercourse acts in
the past three months. Because the number of risky acts
can be very much skewed, the assumptions for the
standard linear regression model are often invalid. Be-
havior assessment as a binary outcome will be analyzed
using a hierarchical logistic regression model. Each
model will include assessment period (baseline = pre
and follow-up = post), a random effect for repeated
within-subject assessments, and test covariates. The test
covariates include intervention factors (e.g., Common
Factors score), provider factors (e.g., capacity), andparticipants’ characteristics (e.g., demographics, baseline
risk-related constructs). Interaction terms between se-
lected covariates and assessment points will be added to
these models to test whether covariates are associated
with change in risk behavior. If an interaction effect be-
tween assessment point and a provider factor is found,
subsequent exploratory analyses will examine the influ-
ence of various provider factors. Direct tests of the in-
fluence of participant-level covariates will be conducted
by entering these variables in the last step of the regres-
sion. We will conduct separate analyses for each of the
four different agency interventions in the effectiveness
studies. To determine the feasibility of this approach to
intervention development, our analysis will focus on
whether these interventions reduce risk behavior. Re-
cruitment of 130 participants by each agency with an
88% retention provides 0.8 power with 0.05 alpha to
detect changes (effects), similar to other interventions,
of 27% decrease in number of risky drug injections in
the past month, and a 24% decrease in percentage having
sexual intercourse without condoms in the past three
months.
We will use qualitative and quantitative methods to
identify agency characteristics, including organizational
barriers and facilitators to inclusion of common factors
and delivery of a high quality intervention, and imple-
mentation context factors, including funding, political
and cultural factors that shape intervention develop-
ment and implementation. Particular attention will be
paid to why facilitators and/or agency directors include
or eliminate common factors, and the organizational
context of intervention implementation, including current
and future agency goals, scope of HIV prevention ac-
tivities, and motivations for developing that particular
intervention [17,23,30,62].
Ethical considerations
This study is approved by the Institutional Review Board
at the Johns Hopkins School of Public Health and the
Ethics Committee of the Sociological Association of
Ukraine. Informed consent is obtained from all partici-
pants, including agency staff and clients. All data col-
lection and reporting will be compliant with US and
Ukrainian privacy laws, and no report will identify
individual participants or study agencies. Data will be
securely stored at Johns Hopkins University, Kharkiv
University, and the Medical College of Wisconsin. All
study records and documents will be stored for no lon-
ger than 10 years after the study has ended.
Trial status
This study began in November 2013 with the recruitment
of eight agencies. In May and June 2013, we completed
the baseline qualitative component of the study, including
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agency, and in-depth interviews with staff and directors at
each agency. In June 2013, we conducted a multi-day
training workshop with agency representatives. In the fall
of 2013, study agencies are developing and manualizing
their interventions. In spring of 2014, video-recorded
agency interventions will be reviewed to determine
whether they include common factors of effective be-
havioral interventions. The agencies whose interven-
tions best reflect the standards of effective behavioral
interventions will enter the second phase of the study in
July 2014 and participate in intervention evaluation to
determine each program’s effectiveness at reducing par-
ticipants’ drug use- and sex-related HIV risk. This phase
will continue through May 2016.
Discussion
Strengths and limitations
This study will use both qualitative and quantitative
methods to explore intervention development processes,
quality of implementation, and organizational factors that
affect provider decisions in intervention development and
implementation. Direct observation (in addition to self-
report) of intervention delivery will provide more accurate
documentation of the extent to which common factors are
incorporated into each agency’s intervention. Direct obser-
vation will enable subsequent analysis of these common
factors within the context of the intervention as a whole
and capture important aspects of intervention delivery,
such as facilitator/participant interactions. Second,
qualitative interviews can more fully capture planning
processes, barriers and constraints to intervention de-
velopment and implementation, and problem-solving
strategies to overcome these barriers than can more
quantitative assessments. Third, the questions this study
attempts to answer regarding the role of organizational
context on intervention development and delivery are
not easily quantifiable and are better suited to qualita-
tive methods. Due to the intensive nature of qualitative
research, we designed this study to compare a small
number of NGOs (eight), sampled for diversity and stra-
tegically selected to reflect key organizational context
criteria, including agency size, target population, and
experience with HIV prevention interventions. Standard
analyses for intervention-control experiments rely on
the use of randomization to ensure that intervention
and comparison groups are comparable with respect to
factors known and unknown that might impact study
outcomes. An effectiveness component based on a ran-
domized controlled trial (RCT) design is not appropri-
ate for several reasons. First, randomization is not
accepted by the frontline service providers with which
we work because they believe that all people who desire
to participate in the intervention should receive it, andresearch participants themselves may not want to be
randomized [63]. Moreover, many of the assumptions
required of an RCT (e.g., participants receive treatment
as intended, attrition does not occur) would likely not
be met given the realities of study participants’ lives (e.g.,
housing instability, dropout due to incarceration or drug
use). In addition, it is likely that each NGO’s intervention
will be unique in reflection of the different contexts in
which it is developed. To be useful, the results of research
must be externally valid — relevant to the population they
intend to reach [64]. Given the aims of this study — to
give frontline service providers the tools to build inter-
ventions that will maximally benefit their populations
and reflect their unique contexts — external validity
was given priority in study design consideration. Be-
cause it is a naturalistic study of the effectiveness of an
intervention as implemented by frontline service pro-
viders, we cannot control for all conceivable threats to
internal validity. Previous research has demonstrated
that the effects of treatment in observational and in
RCTs were similar in most areas, and therefore produce
valid information [65]. Therefore, we will calculate the
effect size at each of the agencies to determine whether
the observed levels of pre-/post-intervention risk reduc-
tion are comparable to those of other behavior change
interventions for drug users.Significance
This study proposes a model of intervention develop-
ment that provides NGO staff with the tools to develop
their own evidence-based prevention programs by teach-
ing them ‘common factors’ of successful HIV prevention
programs. This strategy can potentially increase the cap-
acity of HIV prevention NGOs to conduct theory-based,
multi-session risk reduction interventions [28]. If this
study demonstrates the feasibility of disseminating the
common factors of effective behavior change interven-
tions to frontline service providers, we anticipate several
opportunities to broaden its impact. First, it could lead
to the creation of training modules that emphasize skill-
building and organizational capacity around behavioral
risk reduction strategies more generally, rather than
similar trainings based on specific interventions that
must be significantly modified for new contexts. Sec-
ond, this proposed model of intervention development
could shift the ways in which local HIV prevention ser-
vice providers are trained. By providing local experts
with the tools of prevention intervention development
based on principles of effective behavioral risk reduc-
tions, this model addresses the shortcomings of current
dissemination methods and draws on the knowledge
and experience of frontline service providers as a key
resource in fighting the HIV epidemic.
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